11:54:06 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
RaySearch Laboratories är verksamma inom medicinteknik. Bolaget är specialiserade inom utveckling av mjukvarulösningar för sjukvårdsindustrin. Särskilt område där bolagets produkter används är inom cancervården. Bolagets produkter vidaresäljs som dosplanerings- respektive informationssystem. Olika funktioner inkluderar maskininlärning, beräkningshastighet, automatiserad planering, virtuell simulering, adaptiv terapi och digitala arbetsflöden. Produkterna används av ett flertal kliniker.

Kalender

2022-05-25 Årsstämma 2022
2022-05-18 Kvartalsrapport 2022-Q1
2022-02-23 Bokslutskommuniké 2021
2021-11-18 Kvartalsrapport 2021-Q3
2021-08-25 Kvartalsrapport 2021-Q2
2021-05-27 Ordinarie utdelning RAY B 0.00 SEK
2021-05-26 Årsstämma 2021
2021-05-05 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-11-18 Kvartalsrapport 2020-Q3
2020-08-26 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning RAY B 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-05 Kvartalsrapport 2020-Q1
2020-02-14 Bokslutskommuniké 2019
2019-11-14 Kvartalsrapport 2019-Q3
2019-08-20 Kvartalsrapport 2019-Q2
2019-05-22 Ordinarie utdelning RAY B 0.00 SEK
2019-05-21 Årsstämma 2019
2019-05-09 Kvartalsrapport 2019-Q1
2019-02-20 Bokslutskommuniké 2018
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-23 Kvartalsrapport 2018-Q2
2018-05-31 Ordinarie utdelning RAY B 0.00 SEK
2018-05-29 Årsstämma 2018
2018-05-09 Kvartalsrapport 2018-Q1
2018-02-15 Bokslutskommuniké 2017
2017-11-22 Kvartalsrapport 2017-Q3
2017-08-24 Kvartalsrapport 2017-Q2
2017-05-24 Ordinarie utdelning RAY B 0.00 SEK
2017-05-23 Årsstämma 2017
2017-05-19 Kvartalsrapport 2017-Q1
2017-02-17 Bokslutskommuniké 2016
2016-11-18 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-18 Ordinarie utdelning RAY B 0.25 SEK
2016-05-17 Årsstämma 2016
2016-05-12 Kvartalsrapport 2016-Q1
2016-02-18 Bokslutskommuniké 2015
2015-11-25 Kvartalsrapport 2015-Q3
2015-08-28 Kvartalsrapport 2015-Q2
2015-05-29 Ordinarie utdelning RAY B 0.00 SEK
2015-05-28 Årsstämma 2015
2015-05-08 Kvartalsrapport 2015-Q1
2015-02-12 Bokslutskommuniké 2014
2014-11-27 Kvartalsrapport 2014-Q3
2014-08-27 Kvartalsrapport 2014-Q2
2014-05-28 Ordinarie utdelning RAY B 0.00 SEK
2014-05-27 Årsstämma 2014
2014-05-16 Kvartalsrapport 2014-Q1
2014-02-13 Bokslutskommuniké 2013
2013-11-27 Kvartalsrapport 2013-Q3
2013-08-28 Kvartalsrapport 2013-Q2
2013-05-23 Ordinarie utdelning RAY B 0.00 SEK
2013-05-22 Årsstämma 2013
2013-05-16 Kvartalsrapport 2013-Q1
2013-02-14 Bokslutskommuniké 2012
2012-11-16 Kvartalsrapport 2012-Q3
2012-08-28 Kvartalsrapport 2012-Q2
2012-05-31 Ordinarie utdelning RAY B 0.00 SEK
2012-05-30 Årsstämma 2012
2012-05-23 Kvartalsrapport 2012-Q1
2012-02-16 Bokslutskommuniké 2011
2011-11-24 Kvartalsrapport 2011-Q3
2011-05-26 Ordinarie utdelning RAY B 0.50 SEK
2011-05-25 Årsstämma 2011
2011-05-04 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010
2010-11-12 Kvartalsrapport 2010-Q3
2010-08-27 Kvartalsrapport 2010-Q2
2010-05-26 Ordinarie utdelning RAY B 0.50 SEK
2010-05-25 Årsstämma 2010
2010-05-11 Kvartalsrapport 2010-Q1
2009-11-20 Kvartalsrapport 2009-Q3
2009-08-27 Kvartalsrapport 2009-Q2
2009-05-27 Ordinarie utdelning RAY B 0.00 SEK
2009-05-26 Årsstämma 1
2009-05-15 Kvartalsrapport 2009-Q1
2008-06-25 Split RAY B 1:3
2003-06-10 Split RAY B 20:1
2021-09-30 14:47:33

RaySearch Laboratories AB (publ) announces that Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, is the first center in the world to treat a patient using the RayStation[®]* treatment planning system in combination with Accuray CyberKnife[®] treatment delivery system.

The first treatment - on a patient with brain metastasis - was successfully carried out on September 14. The RayStation module for CyberKnife planning provides support for optimization with the three different collimation types - fixed cones, Iris™ Variable Aperture and Incise™ Multileaf Collimator - and all CyberKnife tracking techniques for Synchrony® real-time motion synchronization.

CHUV has been a RaySearch customer since 2017. In June 2021, the relationship with the clinic was extended as CHUV ordered additional RayStation functionality for automated treatment planning and segmentation using machine learning techniques and support for CyberKnife planning. Further, the center is planning to fully replace its existing oncology information system with RayCare*, to coordinate and optimize its workflows and treatment management. In addition, CHUV was the first center to purchase RayIntelligence®, the innovative cloud-based oncology analytics system launched in December 2020. Eventually, CHUV will conduct all major radiation oncology activities including treatment planning, recording and verifying, workflow management and data analytics exclusively with RaySearch software.

Prof. Jean Bourhis, CHUV says: "This first treatment of a patient with a CyberKnife, while using RaySearch's treatment planning system (TPS) is indeed a great achievement, opening new avenues towards using a single and unified planning system for all our radiotherapy machines. This was made possible due to a great collaboration between the teams from Accuray, RaySearch and CHUV, and the quality of the dose distribution obtained for this patient with this new TPS was amazing."

Johan Löf, founder and CEO, RaySearch, says: "We are very pleased to hear that the first treatment with CyberKnife using RayStation as treatment planning system has been successfully carried out at this world-class center. We are impressed by how fast the system was brought into clinical use, as the added functionality for RayStation was ordered as late as June this year. It is also satisfying to see the strength of collaboration, how industry and healthcare together develop new technique to achieve improved treatment for the patient. We look forward to further deepening our collaboration with both Accuray and CHUV."

Joshua H. Levine, CEO, Accuray, says: "The successful first patient treatment at CHUV using our CyberKnife robotic radiotherapy system with the RayStation TPS represents an important milestone for our organizations and for patients. Working together, the CHUV, Accuray and RaySearch teams are increasing options for planning and delivering precise, personalized radiation treatments that address the unique needs of each patient. CHUV has set an example for other hospitals around the world that want to enhance the care they provide their patients with a CyberKnife System, yet also aspire to simplify their workflow by utilizing a common treatment planning system for all of their radiotherapy devices."

* Subject to regulatory clearance in some markets.